AKT1 and breast cancer: Our previous studies revealed that even at a very low concentration (10nM), BBP, DBP, and DEHP were not only capable of inducing a proliferative effect on breast cancer cells through the PI3K/Akt signaling pathway but also exhibiting estrogenic activity and additive effects when combined with 17β-estradiol [6, 7].